
GENPF
Healthcare · Drug Manufacturers - Specialty & Generic · $636,731 market cap
$0.01040.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 17, 2026 | After the close | — | -0.00 | — |
| Mar 26, 2026 | After the close | — | -0.00 | — |
| Sep 18, 2025 | After the close | — | -0.00 | — |
| Jul 31, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Apr 30, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Jan 31, 2021 | Time not confirmed | 0.00 | -0.01 | — |
| Oct 31, 2020 | Time not confirmed | 0.00 | -0.01 | — |
| Jul 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Oct 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Jul 31, 2019 | Time not confirmed | 0.00 | -0.00 | — |
| Apr 30, 2019 | Time not confirmed | 0.00 | -0.00 | — |
Genix Pharmaceuticals Corporation formulates, manufactures, licenses, and markets life sciences related products with a focus on nutraceuticals and pharmaceuticals in Canada. The company offers generic ophthalmic prescription products, ophthalmic nutraceutical formulations, and prescription generic drugs; ophthalmic OTC products; and eye ointments and drops. It also provides Flu-X, an anti-viral, anti-flu, and…
| Jan 31, 2019 |
| Time not confirmed |
| 0.00 |
| -0.00 |
| — |
| Jul 31, 2018 | Time not confirmed | 0.00 | 0.00 | — |
| Apr 30, 2018 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2018 | Time not confirmed | 0.00 | -0.00 | — |